Vanda Pharmaceuticals (VNDA) Change in Accured Expenses (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Change in Accured Expenses of $1.5 million in Q1 2026, down 83.7% quarter-over-quarter from $9.1 million in Q4 2025, and down 73.74% year-over-year from $5.6 million in Q1 2025.
Vanda Pharmaceuticals' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 73.74% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $11.7 million (up 88.77% YoY), while the FY2025 annual figure was $15.8 million, up 826.23% from the prior year.
- Change in Accured Expenses came in at $1.5 million for Q1 2026 at Vanda Pharmaceuticals, down from $9.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $13.4 million in Q1 2022 to a low of -$10.8 million in Q1 2023.
- A 5-year average of $1.2 million and a median of $1.2 million in 2024 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses jumped 4878.57% in 2022 and plunged 2079.74% in 2025, its largest moves.
- Vanda Pharmaceuticals' Change in Accured Expenses stood at -$3.3 million in 2022, then surged by 201.65% to $3.3 million in 2023, then plunged by 163.85% to -$2.1 million in 2024, then jumped by 526.75% to $9.1 million in 2025, then sank by 83.7% to $1.5 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $1.5 million, $9.1 million, and -$10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Mn |
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | -10.22 Mn |
| Sep 30, 2025 | -10.22 Mn |
| Jun 30, 2025 | 11.33 Mn |
| Jun 30, 2025 | 11.33 Mn |
| Mar 31, 2025 | 5.64 Mn |
| Mar 31, 2025 | 5.64 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | -469,000.00 |
| Sep 30, 2024 | -469,000.00 |
| Jun 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 3.14 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 3.33 Mn |
| Dec 31, 2023 | 3.33 Mn |
| Sep 30, 2023 | -280,000.00 |
| Sep 30, 2023 | -280,000.00 |
| Jun 30, 2023 | -3.24 Mn |
| Jun 30, 2023 | -3.24 Mn |
| Mar 31, 2023 | -10.79 Mn |
| Mar 31, 2023 | -10.79 Mn |
| Dec 31, 2022 | -3.28 Mn |
| Dec 31, 2022 | -3.28 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 306,000.00 |
| Jun 30, 2022 | 306,000.00 |
| Mar 31, 2022 | 13.43 Mn |
| Mar 31, 2022 | 13.43 Mn |
| Dec 31, 2021 | 2.18 Mn |
| Dec 31, 2021 | 2.18 Mn |
| Sep 30, 2021 | -28,000.00 |
| Sep 30, 2021 | -28,000.00 |
| Jun 30, 2021 | 6.16 Mn |
| Jun 30, 2021 | 6.16 Mn |
| Mar 31, 2021 | -5.27 Mn |
| Mar 31, 2021 | -5.27 Mn |
| Dec 31, 2020 | 2.35 Mn |
| Dec 31, 2020 | 2.35 Mn |
| Sep 30, 2020 | 525,000.00 |
| Sep 30, 2020 | 525,000.00 |
| Jun 30, 2020 | 2.68 Mn |
| Jun 30, 2020 | 2.68 Mn |
| Mar 31, 2020 | -1.80 Mn |
| Mar 31, 2020 | -1.80 Mn |
| Dec 31, 2019 | 317,000.00 |
| Dec 31, 2019 | 317,000.00 |
| Sep 30, 2019 | -1.97 Mn |
| Sep 30, 2019 | -1.97 Mn |
| Jun 30, 2019 | 1.65 Mn |
| Jun 30, 2019 | 1.65 Mn |
| Mar 31, 2019 | 3.51 Mn |
| Mar 31, 2019 | 3.51 Mn |
| Dec 31, 2018 | 2.56 Mn |
| Dec 31, 2018 | 2.56 Mn |
| Sep 30, 2018 | -1.61 Mn |
| Sep 30, 2018 | -1.61 Mn |
| Jun 30, 2018 | 1.16 Mn |
| Jun 30, 2018 | 1.16 Mn |
| Mar 31, 2018 | -2.73 Mn |
| Mar 31, 2018 | -2.73 Mn |
| Dec 31, 2017 | 1.40 Mn |
| Dec 31, 2017 | 1.40 Mn |
| Sep 30, 2017 | 1.91 Mn |
| Sep 30, 2017 | 1.91 Mn |
| Jun 30, 2017 | 1.20 Mn |
| Jun 30, 2017 | 1.20 Mn |
| Mar 31, 2017 | 1.44 Mn |
| Mar 31, 2017 | 1.44 Mn |
| Dec 31, 2016 | -1.16 Mn |
| Dec 31, 2016 | -1.16 Mn |
| Sep 30, 2016 | -651,000.00 |
| Sep 30, 2016 | -651,000.00 |
| Jun 30, 2016 | -4.57 Mn |
| Jun 30, 2016 | -4.57 Mn |
| Mar 31, 2016 | 6.96 Mn |
| Mar 31, 2016 | 6.96 Mn |
| Dec 31, 2015 | 1.70 Mn |
| Dec 31, 2015 | 1.70 Mn |
| Sep 30, 2015 | -1.01 Mn |
| Sep 30, 2015 | -1.01 Mn |
| Jun 30, 2015 | -2.11 Mn |
| Jun 30, 2015 | -2.11 Mn |
| Mar 31, 2015 | 10.85 Mn |
| Mar 31, 2015 | 10.85 Mn |
| Dec 31, 2014 | -839,000.00 |
| Dec 31, 2014 | -839,000.00 |
| Sep 30, 2014 | 177,000.00 |
| Sep 30, 2014 | 177,000.00 |
| Jun 30, 2014 | -6.24 Mn |
| Jun 30, 2014 | -6.24 Mn |
| Mar 31, 2014 | 7.93 Mn |
| Mar 31, 2014 | 7.93 Mn |
| Dec 31, 2013 | 916,000.00 |
| Dec 31, 2013 | 916,000.00 |
| Sep 30, 2013 | -861,000.00 |
| Sep 30, 2013 | -861,000.00 |
| Jun 30, 2013 | 1.52 Mn |
| Jun 30, 2013 | 1.52 Mn |
| Mar 31, 2013 | -1.31 Mn |
| Mar 31, 2013 | -1.31 Mn |
| Dec 31, 2012 | -3.11 Mn |
| Dec 31, 2012 | -3.11 Mn |
| Sep 30, 2012 | 845,000.00 |
| Sep 30, 2012 | 845,000.00 |
| Jun 30, 2012 | 2.89 Mn |
| Jun 30, 2012 | 2.89 Mn |
| Mar 31, 2012 | -361,000.00 |
| Mar 31, 2012 | -361,000.00 |
| Dec 31, 2011 | 1.73 Mn |
| Dec 31, 2011 | 1.73 Mn |
| Sep 30, 2011 | 129,000.00 |
| Sep 30, 2011 | 129,000.00 |
| Jun 30, 2011 | -11,000.00 |
| Jun 30, 2011 | -11,000.00 |
| Mar 31, 2011 | -8,000.00 |
| Mar 31, 2011 | -8,000.00 |
| Dec 31, 2010 | -4,000.00 |
| Dec 31, 2010 | -4,000.00 |
| Sep 30, 2010 | -4,000.00 |
| Sep 30, 2010 | -4,000.00 |